Primecap Management Company Has Trimmed By $1.92 Million Its Charles River Lab (CRL) Stake; GOPHER PROTOCOL (GOPH) Sellers Decreased By 12.16% Their Shorts

Charles River Laboratories International, Inc. (NYSE:CRL) Logo

Primecap Management Company decreased Charles River Lab (CRL) stake by 4.04% reported in 2018Q4 SEC filing. Primecap Management Company sold 17,000 shares as Charles River Lab (CRL)’s stock rose 4.92%. The Primecap Management Company holds 404,100 shares with $45.74M value, down from 421,100 last quarter. Charles River Lab now has $6.39B valuation. The stock decreased 0.40% or $0.53 during the last trading session, reaching $131.14. About 112,951 shares traded. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 34.55% since May 15, 2018 and is uptrending. It has outperformed by 30.18% the S&P500. Some Historical CRL News: 16/05/2018 – EVOLUS INC – EXPECTS TO RESPOND TO FDA ABOUT CRL WITH A COMPLETE SUBMISSION TO FDA WITHIN 90 DAYS; 24/04/2018 – Charles River Short-Interest Ratio Rises 48% to 8 Days; 03/04/2018 – Charles River Associates (CRA) Announces Vice President Promotions; 09/05/2018 – Lipocine: CRL Also Identified Additional Comments That Are Not Considered Approvability Issues; 09/05/2018 – LIPOCINE: CRL IDENTIFIED 4 DEFICIENCIES; 26/03/2018 – CHARLES RIVER REFINANCE $1B PACT WITH NEW $1.55B REVOLVING PACT; 10/05/2018 – Charles River Labs 1Q Rev $494M; 15/05/2018 – Alyeska Investment Group Buys 1.3% Position in Charles River; 26/03/2018 – CHARLES RIVER LABS REPORTS REFINANCING OF CREDIT LINES &; 16/04/2018 – APRICUS – PRELIMINARY END-OF-REVIEW MEETING MINUTES SUPPORT PLAN TO ADDRESS ISSUES CITED BY FDA IN ITS FEB 15 CRL FOR VITAROS NDA

GOPHER PROTOCOL INC (OTCMKTS:GOPH) had a decrease of 12.16% in short interest. GOPH’s SI was 54,900 shares in May as released by FINRA. Its down 12.16% from 62,500 shares previously. The stock increased 4.38% or $0.006 during the last trading session, reaching $0.143. About 1.49M shares traded or 110.36% up from the average. Gopher Protocol Inc. (OTCMKTS:GOPH) has 0.00% since May 15, 2018 and is . It has underperformed by 4.37% the S&P500.

Gopher Protocol Inc. engages in the process of developing a real-time, heuristic based, mobile technology. The company has market cap of $30.43 million. The Company’s technology consists of a smart microchip, mobile application software, and supporting software. It currently has negative earnings. The firm was formerly known as Forex International Trading Corp. and changed its name to Gopher Protocol Inc. in February 2015.

More notable recent Gopher Protocol Inc. (OTCMKTS:GOPH) news were published by: Seekingalpha.com which released: “Gopher Protocol: A Risky IoT Bet – Seeking Alpha” on April 15, 2019, also Seekingalpha.com with their article: “Gopher Protocol acquires Fintech assets – Seeking Alpha” published on April 09, 2018, Globenewswire.com published: “Gopher Protocol’s Licensee Released “The Enigma Chip” by Wise — A Collaboration with Gopher Protocol – GlobeNewswire” on November 23, 2018. More interesting news about Gopher Protocol Inc. (OTCMKTS:GOPH) were released by: Globenewswire.com and their article: “Gopher Protocol Has Laid Avant! AI Engine Infrastructure to Handle the GRC – GlobeNewswire” published on June 28, 2018 as well as Globenewswire.com‘s news article titled: “Mobiquity Technologies and Gopher Protocol Announce Share Exchange – GlobeNewswire” with publication date: September 11, 2018.

Among 5 analysts covering Charles River (NYSE:CRL), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Charles River had 8 analyst reports since December 3, 2018 according to SRatingsIntel. The company was maintained on Monday, March 18 by Barclays Capital. On Wednesday, February 13 the stock rating was maintained by Jefferies with “Buy”. KeyBanc Capital Markets maintained it with “Overweight” rating and $151 target in Monday, March 11 report. On Tuesday, March 12 the stock rating was maintained by Jefferies with “Buy”. Morgan Stanley maintained Charles River Laboratories International, Inc. (NYSE:CRL) rating on Monday, December 3. Morgan Stanley has “Equal-Weight” rating and $136 target. Argus Research maintained Charles River Laboratories International, Inc. (NYSE:CRL) rating on Thursday, March 14. Argus Research has “Buy” rating and $170 target.

Since December 4, 2018, it had 0 buys, and 3 sales for $3.28 million activity. The insider BERTOLINI ROBERT J sold $148,179. FOSTER JAMES C had sold 25,000 shares worth $2.88 million.

Primecap Management Company increased Northern Trust Corp (NASDAQ:NTRS) stake by 1.46M shares to 4.86M valued at $406.56 million in 2018Q4. It also upped Amazon.Com Inc (NASDAQ:AMZN) stake by 4,200 shares and now owns 312,678 shares. Burlington Stores (NYSE:BURL) was raised too.

Charles River Laboratories International, Inc. (NYSE:CRL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.